Orexigen Therapeutics, Inc. (OREX) Posts Mixed Q1 Results
Tweet Send to a FriendGet Alerts OREX Hot Sheet
Price: $6.04 -0.17%
EPS Growth %: -355.6%
Financial Fact:
Total operating expenses: 20.26M
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: -355.6%
Financial Fact:
Total operating expenses: 20.26M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade OREX Now!
Orexigen Therapeutics, Inc. (NASDAQ: OREX) reported Q1 EPS of ($0.24), $0.03 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $1.83 million versus the consensus estimate of $640 thousand.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Stage Stores, Inc. (SSI) Posts Surprise Q1 Loss of 2c/Share
- Sina Corp (SINA) Tops Q1 EPS by 5c, Offers Guidance
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
